HPTX Related Analyst Ratings

Apr 8, 2013 07:31 AM JMP Securities Starts Hyperion Therapeutics (HPTX) at Market Outperform

Feb 26, 2013 09:06 AM Needham & Company Maintains Buy on Hyperion Therapeutics (HPTX) Post Q4

Feb 4, 2013 03:12 PM Needham & Company Raises PT on Hyperion Therapeutics (HPTX) to $25 after FDA Approval for Ravicti

Aug 20, 2012 09:58 AM Cowen Starts Hyperion Therapeutics (HPTX) at Outperform

Aug 20, 2012 07:57 AM Leerink Swann Starts Hyperion Therapeutics (HPTX) at Outperform; Attractive Opportunity in Orphan Drug Model

Aug 20, 2012 07:36 AM Needham & Company Starts Hyperion Therapeutics (HPTX) at Buy; Commercial Opportunity for Navicti